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Abstract
Stress response mechanisms in bacteria helps them sustain stressful and com-
petitive environments caused by nutrient limitation. Often these stresses give rise
adaptive phenotypes that are evolutionarily fitter under nutrient limitation. These
phenotypes possess favorable adaptations that help them scavenge and recycle
amino acids, carbohydrates, and lipids from other cells, thus playing a crucial role
in their survival.
The objective of this project was to develop a systematic procedure to pro-
duce evolutionarily fitter populations of E.coli to test the following hypotheses -
(1) Bacteria that show increased fitness after being subjected to stress and can
outcompete their naïve counterparts in a limited resource environment. (2) This
increased competitiveness could be exploited to develop a new class of metabol-
ically efficient, contamination resistant host organisms for industrial biotechnol-
ogy.
E.coli cultures were exposed to a nutritionally stressful scenario by aging them
in fed-batch cultures. Upon competing the aged cultures with the naïve ones it
was observed that the aged cultures prevail over the naïve ones. This is due to a
previously observed phenomenon called Growth Advantage in Stationary Phase
(GASP), which is believed to be the result of beneficial physiological changes in
cells due to imposed nutritional stress.
The metabolic burden imposed on the cells was measured by calculating the
doubling time. The doubling time served as a proxy for calculating the fitness of
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stress hardened cells. Metabolic burden for cells containing plasmids and cells
where this plasmid was integrated on the chromosome was measured to charac-
terize the relative metabolic advantage of the integrands over cells with. It was
observed that the cells with plasmids experienced higher metabolic burden.
Heterologous protein expression in the stress hardened cells was analyzed to
determine if the physiological changes influence protein expression. GFP was
used for testing the protein expression. The stress hardened cells showed an ap-
proximate two fold increase in the expression of GFP which was a surprising
result as the increased production of GFP is not beneficial for the cell in itself.
The stress hardened GASP phenotypes could be used as a chassis for pro-
ducing commercially relevant proteins and antibiotics. The GASP phenotype is
contamination resistant as it is capable of surviving in a nutrient limited condi-
tion. This phenotype shows slower growth rate and increased protein production
implying that these cells could produce more product for the same amount of
materials hence reducing the production cost. Thus, the GASP phenotype could
serve a robust chassis for synthetic biology because of the beneficial adaptations
it acquires.
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Chapter 1
Introduction and Literature Review
1.1 Synthetic biology
The rise of biotechnology and biomolecular engineering depends on the
ability to efficiently manipulate gene sequences using polymerases, restriction
endonucleases and ligases to create novel functional genetic constructs for
applications ranging from healthcare to recombinant enzyme production. For last
30 years, this field has been almost exclusively devoted to cloning recombinant
genes with a view of creating microbial cell factories. More recently an
engineering approach to biotechnology has driven the field towards assembling
cellular systems from well-characterized biological parts with reliable and
predictable outcomes (1; 2). The focus has shifted from importing mere
funtionality into the cell to importing the associated spatial and temporal controls
of the funtionality. The progress in this field has been helped by the reduction in
cost of chemical DNA synthesis and the use of model-guided circuit assembly
that aids rapid construction and evaluation of genetic circuits (3).
Synthetic biology is formally defined as the design and fabrication of
biological components and systems that do not already exist in the natural world
and / or the re-design and fabrication of existing biological systems
(www.syntheticbiology.org).
The foundational principles of design in synthetic biology espouse common
engineering practices such as abstraction, standardization and modularization.
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Abstraction is a method by which complex information is hidden for practical
purposes by representing it with readily comprehensible linguistic or graphical
notations. Abstractions highlight information relevant to functionality of a
biological molecule while hiding details such as its structure, which have limited
relevance to using the biomolecule. At this level the synthetic biologist is
concerned only with the system hierarchy such as parts and devices. The
hierarchy is organized in such way that there is only limited and required
exchange of information between parts, devices, and systems (4). Abstraction
enables decoupling design from construction. The ultimate goal of synthetic
biology is to be able to design synthetic system with predictable behavior and
high levels of abstraction using the engineering tools available (5).
Engineering biology depends on design, abstraction and design decoupling
which leads to standardization of biological parts. These parts are therefore
required to be both physically and functionally reliable (6; 7). The registry of
standard biological parts, BioBricksT M, housed at Massachusetts Institute of
Technology is a collection of standardized biological parts that encode for the
promoters, terminators, enzymes, activators, repressors, reporters, and ribosome
binding sites (Registry of Standard Biological Parts, 2010). Prototypes of genetic
devices can be created quickly with the help of the standardized parts from
BioBricksT M (8; 9). Individual parts that fail to function as per the design
requirements can be identified and replaced easily with ones that function and fit
the design after rigorous testing and characterization (10). Parallel assembly of
higher order devices can improve the development of synthetic gene circuits (11).
The International Genetically Engineered Machine (iGEM) is a worldwide
competition aimed at promoting synthetic biology ideas in undergraduate
programs. The undergraduate teams are provided with a kit of biological parts
from the Registry. The students work towards desgining and building biological
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systems and testing them in living cells using these parts and new parts designed
by them. The vision behind the Parts Registry is for it to serve as a resource for
synthetic biologists. The synthetic biologists would design a system comprising
of numerous biochemical processes and then implement the design with well
characterized parts using standardized methods of assembly. The behavior of this
device is characterized to produce a datasheet. This datasheet is used as an
interface between the engineers and the device (7; 12).
One of the earliest demonstrations of synthetic biology was the genetic
toggle switch by Gardner et al (13). This circuit could control gene expression
between on and off states depending on the external stimuli. This synthetic
genetic toggle switch employs a pair of promoters encoding mutually repressing
regulators. This mutual repression is analogous to the lysis-lysogeny switch
observed in bacteriophage λ . This bacteriophage λ has two promoters that
mutually repress the gene product of the other thus helping the organism to
switch between the lysis and lysogeny states of bacteriophage infection (14). The
PL promoter from the bacteriophage λ was used with lacI repressor to repress the
Ptrc2 promoter. The Ptrc2 promoter controlled the expression of the temperature
sensitive Cl-ts gene that translates into the λ Cl repressor protein which in turn
represses the PL promoter. The third variant used the PLtetO−1 promoter with Tet
repressor. The system was manipulated using two different exogenous signals in
order to activate gene production from each promoter and expression could be
toggled between them. When one of the signals was removed,the system retained
its current state, thus satisfying all the requirements of a toggle switch (13).
At the same time, Elowitz and colleagues developed a genetic oscillator
circuit where three transcriptional repressors, each repressing the next were
assembled to give rise to oscillations in the levels of transcriptional factors
produced (15). LacI protein represses the transcription of the tetR gene from
3
Figure 1.1. Toggle switch design.
Repressor 1 inhibits transcription from Promoter 1 and is induced by Inducer 1.
Repressor 2 inhibits transcription from Promoter 2 and is induced by Inducer 2
(13).
tetracycline resistant transposon Tn10. This protein product in turn represses the
transcription of the CI protein from bacteriophage λ , which in turn represses the
lacI expression under the first promoter. This transcriptional activity was
measured by green fluorescent protein expression on a separate reporter plasmid
(15).
More recent examples of synthetic gene circuits include modular positive
feedback-based gene amplifier comprising of a Taz sensor kinase and an OmpR
regulator as shown in Figure 1.3 (16; 17). Aspartate, the inducer molecule binds
to the Taz sensor kinase and causes OmpR to autophosphorylate which in turn
activates OmpC promoter expressing LuxR (18). This in turn triggers the activity
of pLuxI promoter expressing a LuxR-GFP construct. The signal from
LuxR-GFP further up regulates the activity of its own promoter thereby making
it behave in a positive feedback loop (19).
Another example of a tunable synthetic gene circuit for amplifying cellular
oscillations is shown in Figure 1.4 (20; 21). The circuit was constructed using a
hybrid promoter (Plac/ara−1). This promoter is composed of the activation site
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Figure 1.2. Repressilator design.
A cyclic negative feedback loop comprised of three repressor genes with their
respective promoters (15).
from araBAD operon and the repression sequence from lacZYA operon (22).
AraC protein activates the promoter in the presence of arabinose and LacI
represses it in the absence of isopropyl β -D-1-thiogalactopyranoside (IPTG).
AraC, LacI and a monomeric yeast-enhanced green fluorescent protein
(yemGFP) reporter were placed under three identical copies of Plac/ara−1
promoter to give rise to co-regulated transcription modules. In the presence of
arabinose and IPTG the promoters transcribes the elements under their control.
There is an increased production of AraC, as it is in a positive feedback loop.
The increase in the production of LacI triggers the negative feedback loop,
thereby decreasing the promoter activity. This differential activity between the
two feedback loops results in oscillatory behavior. This circuit designed by
Stricker et al (21) is an improved version of the oscillatory circuit designed by
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Figure 1.3. Positive feedback amplifier.
The two-component sensor consists of the Taz sensor kinase and the OmpR
response regulator. Taz controls the level of phosphorylated OmpR (OmpR-P),
which in turn activates the expression from the PompC promoter. When the Taz
sensor kinase is bound with aspartate, it increases the levels of OmpR-P, leading
to increased expression from the PompC promoter (16).
Elowitz et al (15) where the former is capable of tuning the oscillations in the
circuit based on external stimuli.
Figure 1.4. Oscillations in the dual-feedback circuit.
Hybrid promoter Plac/ara−1 controls transcription of araC and lacI forming a
positive and negative feedback loops (20).
6
1.1.1 Applications of synthetic biology
Synthetic biology could potentially address universal challenges like energy
security, bioremediation, improving health, and increasing food and agriculture
yields. Successful implementation of these applications could revolutionize the
world. Some of the examples of the application of synthetic biology are
recounted below.
Energy
Mycoplasma laboratorium is a partially synthetic species derived from the
genome of Mycoplasma genitalium. This was the first of its kind synthetic
organism created at the J. Craig Venter Institute (23). In an approach
significantly distinct from engineering microorganisms for biofuel production it
has been speculated that organisms that can produce biofuel can be created de
novo. M.laboratorium has the potential to be exploited for biofuel production.
LS9 uses principles from synthetic biology and metabolic engineering to
design and build biosynthetic pathways. They have successfully exploited
microbial fatty acid metabolism to produce various fuels at a commercial level.
They are currently collaborating with Chevron.inc to develop a sustainable
hydrocarbon diesel product (http://www.ls9.com).
Microbial production of butanol via Clostridium acetobutylicum produces
extremely low yields of butanol mixed with acetone and ethanol (24). To
increase the yield of butanol standard fermentation pathways in Clostridium
acetobutylicum were bypassed and a set of 2-keto acid intermediates of E. coli
amino acid biosynthesis were synthetically shunted to increment the yields of
butanol in two enzymatic steps (25).
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Environment
Synthetic biology has also found application in the field of bioremediation.
Atrazine which is present in most commercially used herbicides often seeps in to
potable water. E. coli has been engineered to consume atrazine and degrade it to
less harmful products. The by-products and bacteria can both be recycled (26).
Pseudomonas aeruginosa can be used for bioremediation of 2-chlorotoluene . A
hybrid pathway has been built in P. aeruginosa to degrade 2-chlorotoulune CO2
and chloride (27; 28). Biosensors to detect arsenic, mercury, chromium and other
such hazardous pollutants are being developed (29). E. coli cells have been
engineered to fluoresce after contact with arsante or arsenite. This biosensor
could consistently differentiate concentrations of 10-50 µg arsenite per liter of
drinking water (29).
Health
De novo construction of mevalonate pathway in E. coli has improved the
production of a precursor to artemisinin, an anti-malarial drug (30; 31; 32).
These precursors were earlier extracted from the bark of Artemisia annua which
greatly limited the drug production. With E. coli as the host organism production
of the drug could be scaled-up while simultaneously decreasing the production
time. The decrease in production time and scale up of the drug directly affected
the cost of the drug, making it cheaper.
Nonlytic M13 bacteriophages were engineered to produce synthetic
adjuavants to enhance the killing efficacy of the antibiotics. This method
disturbed the existing defense mechanisms that bacteria have for antibiotic
defense (33; 34).
Cancer invading bacteria were designed to target specific tumorigenic
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pathways in vivo using RNAi (35). The bacteria were desgined to knock down
the expression of CTNNB1 (β -1 catenin) gene which initiates colon cancer. The
bacteria generated short hairpin RNA (shRNA) segments that induced cleavage
of the CTNNB1 mRNA transcripts. In addition to shRNA, the bacteria also
possessed a synthetic system that enabled molecular efflux (35).
Food and agriculture
The 2011 iGEMT M team from Yale developed an antifreeze protein (AFP)
from a Siberian beetle called Rhagium inquisitor that could prevent formation of
ice crystals. Antifreeze proteins could be used for cryopreservation of food and
for extending the crop growing seasons. The team employed protein engineering
by directed evolution to evolve novel variants of the AFP
(http://2011.igem.org/Team:Yale/Project/Introduction). They quantified the
protein expression, purified it, and then subjected it to directed evolution thereby
cloning three new variants. MAGE (multiplex automated genome engineering)
was used for creating diversity in sequences over a large population of cells by a
oligo mediated allelic replacement (36). AFP from Rhagium inquistor (RiAFP)
bears no homology to the antifreeze proteins from fish which are currently used
as RiAFP has only one disulfie bond hence is less tightly folded. Being a small
protein (136 amino acids) it was easily to produced in E coli.
1.2 Metabolic burden in synthetic gene circuits
Synthetic biology offers a bottom up approach to understanding and building
gene circuits from well characterized components (37; 38; 39; 40; 41). The
aforementioned circuits exemplify model guided bottom-up assembly of gene
circuits as a key paradigm in synthetic biology design. However, the field is still
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far from its goal of creating standardized and autonomous biological circuit
design that could function robustly, independent of native gene networks or even
functionally substitute endogenous circuitry altogether (42).
Figure 1.5. Types of synthetic manipulation in genetic circuits.
(A) Wild type cells can be modified in two ways. (C) Rewiring the cell’s innate
circuitry to perform the desired function. (D) Integrating a synthetic network in
the cells innate circuitry to perform the same function. (E) The original network
in the cell is replaced completely by a synthetic circuit. (B) Introducing a
synthetic network in addition to the cell’s innate network. (F) Introducing a fully
autonomous circuit that operates independently of the cellular milleu (43).
Emerging scholarship suggests a classification system for evaluating
increased complexity in Figure 1.5. The authors suggest that the circuit depicted
in Figure 1.5 (F) (43) suggests an ideal scenario where the synthetic gene circuit
introduced would be completely autonomous and be independent of the native
cellular network and would have no interactions with the cells innate network.
In the process of modifying cells synthetically, cells are often assumed to be
static black box which belies the complexity of the system. This assumption of
treating the cell like a black box ignores the inevitable effects of cells’ innate
circuitry has on the synthetic network and vice versa. This assumption of
decoupled circuits from cells is best acceptable for a short time-scale when the
cells are in their exponential phase of growth in nutrient rich medium. The long
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term behavior of these synthetic circuits need to be studied and characterized as
the applications that would rely on these circuits could span a longer period of
time. This would require detailed analysis of how the cell behaves past the
exponential phase and with increasing nutritional stress.
Thus-far there have been limited studies on the long term behavior of
synthetic networks and their stability under nutritional stress. It is a known fact
that extra-chromosomal plasmids rely on the native cellular replication
machinery which necessarily argues against the decoupling of synthetic and
endogenous gene circuits. In the process of depending on the cell for its
energetic and other requirements, synthetic gene circuits impose a metabolic
burden on their cellular chassis. In order to better understand how synthetic gene
circuits would behave in long term under changing environments including, but
not limited to nutrient limitation, the following questions need to be answered
Figure 1.6. Behaviour of synthetic circuits in long-term experiments.
1. How does a gene circuit impose metabolic burden on the cell?
2. How does the cellular physiology change in response to the metabolic
burden?
3. How do changes at the single cell level manifest at the population level?
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4. How does the population dynamic modulate the apparent behavior of the
gene circuit?
The central thesis of this project was to characterize how cells alter their
physiology in response to increasing metabolic burden in long-term nutrient
depleted culture conditions.
1.3 Physiological changes in a cell culture in
response to metabolic burden
Microorganisms encounter stressful starvation-like conditions in their natural
ecological niches which is unlike the resourceful growth they enjoy in laboratory
cultures (44). A dynamic ecological equilibrium exists in nature where the
microbes constantly evolve with time in order to survive an ever changing
environmental landscape. Microbial adaptation to nutritional stress has been
extensively addressed using E. coli as a model organism (44). An emerging
conclusion from these studies is that starved cells undergo significant changes in
physiology to help and metabolize alternate nutrients, which they otherwise
would not use. This adaptive evolution is critical for cellular survival.
The canonical cell growth curve in Figure 1.7 distinguishes between four
stages of cell growth namely- lag phase where the cells are adjusting to the
environment, log phase where they grow exponentially using all the readily
available nutrients, the stationary phase where the growth curve is equivalent to
the death rate causing the curve to reach a stationary maximum value. At this
stage the nutrients are scarce and soon after this stage the growth rate drops
leading to the death phase.
In reality 99% percent of the cells die as they are rendered incapable of
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Figure 1.7. Growth curve graphs.
Graphs showing the theoretical growth curve the emergence of GASP
phenotypes after the death phase
carrying out repair and maintenance functions due to accumulation of oxidatively
damaged proteins and nucleic acids (45). The remaining 1% of cells that manage
to survive the death phase gain the ability to catabolize the remains of other cells
to obtain amino acids from proteins, carbohydrates from the cell wall, lipids from
cell membrane material and even information from DNA (46). This phase is
called the long term stationary phase. The phenotype that emerges during this
phase has a significant adaptive advantage and is called the Growth Advantage in
Stationary Phase (GASP) phenotype (44; 47; 48; 49).
One of the hallmarks of the GASP phenotypes is ability of cells aged in long
term batch cultures to outcompete cells from younger cultures (50). The cells
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maintain the advantage even when subjected to repeated rounds of serial passage
indicating that GASP phenotypes are heritable and are not just a temporary
physiological adaptation (48). Four GASP mutations have been identified so far
of which two loci have been well characterized (48; 49; 51; 52). The first
mutation identified was in rpoS, which encodes the alternative sigma factor RpoS
or σS. RpoS is a stationary phase-specific sigma factor responsible for global
changes in gene expression at the onset of stationary phase mainly due to carbon
starvation. RpoS regulates the physiological state of the cell by controlling the
overall metabolism, pH, osmotic balance, temperature and oxidative stresses.
(48; 49) The other mutation that has been studied has been mapped on the lrp
which encodes the leucine- responsive protein (49; 51; 52). The activity of Lrp is
controlled by the leucine levels within the cell. The Lrp regulon mainly includes
genes responsible for amino acid metabolism and transport. Amino acid
metabolism is regulated by Lrp regulin by increasing anabolism and decreasing
catabolism (53; 54)
Figure 1.8. Dynamic emergence of GASP phenotypes (50).
The emergence of GASP phenotype is graphically depicted in Figure 1.6 that
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quantifies cellular viability as log CFU/ml as a function of time. From the figure
it can be seen that the net cellular viability remains constant through time. The
emerging subpopulations represented by colored lines are the dynamically
evolving GASP phenotypes which constantly displace the less fit siblings. The
GASP phenotypes sweep through the population displacing remaining cells until
it gets displaced by the next phenotype with increased fitness (47; 48; 55). There
exists a genotypic homogeneity with functional diversity indicating the possible
emergence of a dynamically evolving ecosystem (44).
Cells harboring synthetic gene networks on plasmids or as chromosomal
integrants sustain significant metabolic burden. This in turn causes the host to
rapidly uptake more nutrients than it would otherwise leading to quick exhaustion
of available nutrients initiating the early onset of starvation like conditions. The
lack of nutrients drive the cells to adapt to the nutrient-depleted environment by
bringing about necessary physiological changes in order to thrive (56).
It has been observed and confirmed that adaptive phenotypes emerge as cells
age (57; 58; 59; 60). These cells develop physiological changes that optimize
cellular fitness empowering the cells to perform better even though growth rate is
reduced owing to the increase in metabolic burden.
1.4 Specific aims of the project
In this research we investigate the potential use of cells exhibiting a
GASP-like phenotype as a metabolically robust chassis for synthetic biology.
GASP phenotypes are know to thrive under nutrient depleted condition unlike
the naïve cells. Propagation and maintenance of the synthetic gene circuits
adversely affect the cell’s ability to grow and reproduce. GASP phenotypes being
more resilient to harsher environments are more robust and could possibly
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support synthetic gene networks over a longer time period. This fact makes
GASP phenotypes ideal for applications where conditions cannot be controlled
or monitored.
Specific aims of this project are described as follows
1. To reproduce the Growth Advantage in Stationary Phase (GASP)
phenomenon - GASP phenotypes are more robust and contamination
resistant. The aim to reproduce the GASP phenomenon is to test the
consistency of its occurrence. This would be an indicator if these cells
would be suitable as a chassis for synthetic biology. Recurrence of this
phenomenon ensures reliable availability of these cells.
2. To analyze the metabolic burden imposed on cells due to the presence of
plasmids- The presence of synthetic gene circuits imposes a metabolic
burden. This aim would test the tolerance these cells would have to
metabolic burden imposed on them.
3. To explore the effect of GASP on heterologous protein expression- This
aimed at testing the ability of heterologous protein expression of the GASP
phenotype as compared to the non-GASP phenotype.
The following chapters contain a detailed description of the experimental
protocols followed and the results obtained.
16
Chapter 2
Materials and Methods
2.1 Growth conditions and media
All cultures experiments were performed in Luria-Bertani broth (LB) and M9
minimal media. The composition for LB media is listed below in Table 2.1. The
ingredients were added to 1 l deionized water and autoclaved at 121°C and 15
psi. M9 minimal media was used in experiments to rule out any media
dependency that the cells might have acquired. 5x M9 media solution was
prepared as shown in Table2.2. The compounds were dissolved in 1 l water and
autoclaved at 121 °C and 15 psi. 1x M9 media used in the experiments was made
as mentioned in Table2.3. All the experiments were performed at 37°C unless
otherwise mentioned. All antibiotics along with their concentrations used are
listed in Table 2.4. All chemicals were purchased from Sigma-Aldrich (St.
Loius, MO).
Table 2.1. Luria - Bertani broth
Ingredients Quantity
Na2HP04.7H2O 30 g
KH2PO4 15 g
NaCl 2.5 g
NH4Cl 5 g
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Table 2.2. 5x M9 Minimal Media
Ingredients Quantity
Na2HP04.7H2O 30 g
KH2P04 15 g
NaCl 2.5 g
NH4Cl 5 g
Table 2.3. 1x M9 Minimal Media
Ingredients Quantity
Sterile DI water 800 ml
M9 salts 5X stock solution 200 ml
Autoclaved 1M MgSO4 1 ml
Autoclaved 1MCaCl2 0.1 ml
Glucose 0.4%
Table 2.4. Antibiotics
Antibiotic Concentration
Ampicillin 100 µg/l
Kanamycin 40 µg/l
Chloramphenicol 34 µg/l
2.2 Experimental methods and protocols
2.2.1 Absorbance and fluorescence assays
Growth curves were obtained by measuring the absorbance of the cells at
OD600 after sub-culturing an over-night at 1% dilution in fresh LB medium.
Samples were transferred to a 96 well plate (Nalgene, Thermo-Scientific, NY)
and the relative fluorescence (587/610 nm for mCherry and 515/528 nm for
pVenus) and optical density at 600nm (OD600) were measured using Tecan
infinite M200 microplate reader. The fluorescence readings normalized as
relative fluorescence units (RFU) with OD600 absorbance to account for cell
density. All experiments were performed in triplicates.
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2.2.2 Fluorescence Activated Cell Sorting (FACS)
200 µl cell sample from the 96 well plate was extracted and spun down at
15,000 rpm and re-suspended in 1 ml of 1x PBS with chloramphenicol and kept
at 4°C until the samples were ready to be analyzed by Fluorescence Activated
Cell Sorting (FACS). The MoFlo Sorter used for the experiment (Dako
Cytomation, Ft. Collins, CO) is a multi-laser, high-speed sorter with multi-color
analysis capability. The equipment was set to count 100,000 events. The lasers
utilized on the equipment are green and yellow to excite the yellow fluorescent
marker- pVenus and red fluorescent marker PmCherry respectively.
2.2.3 The LacZ competition experiment
The LacZ competition experiment served as the preliminary experiment to
reproduce the GASP phenomenon. The cells used for this experiment were
wildtype E. coli K12 MG1655 (F− λ− ilvG- rfb-50 rph-1) cells. The basis for
this experiment is that K12 cells could metabolize lactose due to the presence of
an intact lac operon. Lac operon consists of three parts lacZ, lacY and lacA
where lacZ encodes β -galactosidase. This enzyme degrades lactose into glucose
and galactose which the cell can readily consume. In presence of
5-bromo-4-chloro-indolyl-galactopyranoside (X-gal) which is a lactose analog,
β -galactosidase, enzyme product of the lacZ gene cleaves it to produce galactose
and a dimerized indole ring that produces the characteristic blue color in colonies
showing the presence of an intact LacZ gene.
The wild type strain with an intact lac operon was denoted as LacZ+ . A
LacZ- was constructed by P1vir transduction of a kanamycin resistant gene
cassette from BW2952 ( F- araD139 ∆(argF-lac) U169 rpsL150 deoC1 relA1
thiA ptsF25 flbB5301 rbsR malG::λplacMu55 Φ(malG::lacZ)) to MG1655. The
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Figure 2.1. Action of β galactosidase. The enzyme cleaves Xgal into galactose and
5-bromo-4-chloro-3-hydroxyindole which immidiately dimerizes to 5,5’
dibromo - 4,4’ dichloro-indigo which gives blue color.
steps of lysate preparation and transduction are described below:
Lysate preparation and transduction
An overnight culture of the donor strain BW2952 possessing the kanamycin
insert was made. The donor strain over night culture was diluted to a ratio of
1:50 into fresh LB medium with 5 mM CaCl2 and 0.2% glucose. The subculture
was grown for 1-2 hours until visible growth was observed. Few drops of the P1
phage lysate were added to the subculture and incubated for 3h until the cultures
lysed. Chloroform was added to the lysate to kill the phage and thoroughly
mixed. The cell debris was discarded by centrifugation and the lysate was stored
at 4°C until further use. The recipient strain MG1655 was grown overnight in 4
ml LB. The overnight culture was centrifuged at 3000 rpm for 5m and
resuspended in equal volume of fresh LB medium with 5 mM CaCl2 and 100
mM MgSO4. Two - three drops of donor P1 lysate prepared above were added
and incubated at 37°C for 30-45 minutes. 200 µl of 100 mM Na-citrate and 1 ml
of LB medium was then added to the recipient strain and grown for 1.5-2 h. The
cells were centrifuged at 3000 rpm for 5m and resuspended in 200 µl fresh LB
with 100 mM Na-citrate and spread on kanamycin selective plates and incubated
overnight at 37°C. The LacZ- colonies obtained the following day were streaked
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twice on plates containing kanamycin and sodium citrate to avoid phage
contamination.
For selection purposes both these cell lines were transformed with pBR322
possessing both ampicillin and tetracycline resistance markers. LacZ+ and LacZ-
cells were aged by growing them for 40 hours in LB medium. OD600 was
measured every hour and aliquots were withdrawn every hour to make freezer
stocks for further experiments.
Calibration of X-gal metabolism for LacZ experiment
The assay was developed to quantify the activity of the LacZ gene, which
would serve as a proxy for the proportion of LacZ+ cells in a mixture of LacZ+
and LacZ- cells. Traditionally X-gal the selection is used in solid cultures as a
visual marker to aid selection of genetically engineered transformants. In order
to use it in liquid cultures to identify the maximum activity of lac operon in
presence of X-gal, following three quantities had to be determined-
1. The concentration of X-gal that could be used to differentiate between
cells.
2. The time at which cells start metabolizing X-gal.
3. The wavelength where the dimerized indole ring would have maximum
absorbance
Competition assay
Aged K12 cells were competed against younger cells to test which of the two
would prevail. For this, freezer stock samples of LacZ+ and LacZ- cells from
hour 2 and hour 20 were selected.
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Overnight cultures of LacZ+ and LacZ- from hour 2 and hour 20 were grown
in LB supplemented with ampicillin in 10 ml culture tubes. OD600 of the
overnight cultures were measured to ensure that it was similar and sub-cultured
such that the OD for both the cells was approximately 0.02. The cells from
LacZ+ hour 20 and LacZ- hour 2 were mixed in a 1:1 ratio in two sets - one with
50% X-gal and other 0% X-gal. The experiment was also set with LacZ+ hour 2
and LacZ- hour 20 as control. Point reads of OD were taken hourly after 6 hours
of incubation. 10 µl sample of cells was also plated on the agar plates containing
ampicillin and X-gal every hour. These plates were incubated for 20 hours at
37°C.
2.2.4 Construction and aging of DH5α cells for competition
assay
The cells used in these set of experiments were E. coli DH5α (F- endA1
glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZ ∆M15 ∆(lacZYA-argF)
U169, hsdR17(rK− mK+), λ -). For the ease of differentiating, cells were
transformed with identical plasmids which differ only with respect to the
fluorescent protein marker. The plasmids have a R6K origin, kanamycin
resistance marker and mCherry and pVenus as the fluorescent reporter. These
plasmids were kindly gifted by Prof. C.V Rao (ChBE,UIUC).
Overnight cultures of DH5α cells was grown. 50 ml of LB media was
inoculated in 1:100 dilution from the overnight culture and grown for 4h. They
were spun down and washed with 10% glycerol three times. The DH5α cells
were then resuspended in 200µl 10% glycerol to make electrocompetent cells
and stored at -80°C until further use.
Electrocompetent DH5α were transformed with plasmids pVenus and
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mCherry via electroporation to obtain the cell lines mC-DH5α and pV-DH5α .
mC-DH5α and pV-DH5α cells were grown in 50 ml LB medium. Aliquots were
withdrawn from these samples consecutively for the first three days to make
freezer stocks. After the first three days aliquots were obtained every three days
to make freezer stock samples. Along with making freezer stock, 10 ml of the
sample was replaced by 10 ml of fresh LB media every three days to ensure the
propagation of cells and to enrich any emergent GASP phenotypes. The samples
were aged by growing for 15d.
2.2.5 Competition assay
Competition assay was conducted between samples from days 2, 12 and 15.
Overnight cultures of mC-DH5α and pV-DH5α cell lines from days 2, 12, and
15 were started in LB under kanamycin selection. The OD600 of the overnight
cultures were measured and sub-cultured such that the OD for the cells was
approximately 0.02. The competition assay was set up between aged pV-DH5α
cells and unaged mC-DH5α cells and aged mC-DH5α and unaged pV-DH5α
cells i.e. pV-DH5α day2 with mC-DH5α day 12 and mC-DH5α day 15 and vice
versa in 1:1 dilution. The whole experiment was set up on a 96 well plate with
triplicates and conducted over 18h. The samples used for Fluorescence Activated
Cell Sorter (FACS) were also set on the plate. Absorbance and fluorescence
reading were taken by the spectrophotometer to monitor growth and fluorescence
to monitor the expression of protein. The spectrophotometer was set at 37 °C
with an orbital shaking set to 250rpm between reads. Hourly reads of absorbance
and fluorescence were taken for 18h and samples for FACS were also withdrawn
every three hours from the plate. These samples was spun down and resuspended
in 1x PBS with cholramphenicol and stored at 4°C until ready to be analysed by
flow cytometry. The genomic DNA from all the cells used for the competition
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Figure 2.2. Plasmid map of mCherry.
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Figure 2.3. Plasmid map of pVenus.
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assay was extracted and the rpoS was amplified using PCR and was sequenced.
2.2.6 Construction of cells with plasmids integrated in
chromosome
Multiple copies of plasmids get reduced to a single copy when integrated in
the chromosome. The method of integration used here is based on
Conditional-Replication Integration and Modular (CRIM) system (61; 62). E.
coli K12 MG1655 strains were used for this experiment.
E. coli K12 pir-pINT (J72008) cells were made electrocompetent (61). The
electrocompetent K12 cells were transformed with mCherry fluorescent protein
on a CRIM plasmid and pVenus fluorescent protein on CRIM plasmid via
electroporation. These transformed cells were grown at 30°C on plate with
kanamycin to select for cells with resistance. The pir-pINT helper plasmid has a
temperature sensitive origin of replication due to which it is grown at 30 °C.
During this incubation the CRIM plasmid replicates into multiple copies in
presence of the pir protein. A single colony from the plate is picked and grown to
saturation (OD600 close to 1.6) in 5 ml LB medium with kanamycin at 37°C. The
cells from the liquid culture were plated on agar plates with LB and kanamycin
and incubated overnight at 43°C. This temperature cures the cell of the helper
plasmid which has a temperature sensitive origin. From the plate at 43°C a single
colony was picked and grown to saturation in 5 ml LB with kanamycin and
plated on agar plates with LB and ampicillin to confirm the loss of helper
plasmid since the helper plasmid has an ampicillin resistance marker. Cells were
also plated on agar plates with LB and kanamycin for confirmation. Genomic
DNA was isolated from the resulting colonies on the agar plate with kanamycin
and analyzed to confirm integration of the CRIM plasmid. The φ80 locus from
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the chromosome was PCR amplified out to confirm the integration.
Assay for metabolic burden
The integrated cells, K12 with mCherry-RB01 and K12 with pVenus-RB02
were used to compare metabolic burden with mC-DH5α and pV-DH5α which
were cells with plasmids. Overnight cultures of mC-DH5α and pV-DH5α and
RB01 and RB02 were grown. These cells were sub-cultured in 1:100 dilutions.
Absorbance at OD600 was measured every 10 minutes for all the cell samples.
The experiment was set up on a 96 well plate in triplicates. The data obtained for
the growth curve was fit to the following logistic growth model for analysis.
y =
(
Asymptote
1+ e
Xmid−input
scal
)
(2.1)
Where,Asymptote represents the maximum carrying capacity
Xmid represents represents the time taken to get to half of the asymptotic
value
Scal is inversely proportional to the growth rate of the culture
The metabolic burden imposed on the cells by the plasmids was analysed by
calculating the doubling time. Doubling time was compared with cells which had
the construct integrated on chromosome.
2.2.7 Heterologous protein expression in GASP phenotype
The integrated cells, K12 with pmCherry -RB01 and K12 with pVenus -
RB02 were aged in the same way as mC-DH5α and pV-DH5α and freezer
stocks were made fromthem every three days. The naïve and day 15 cells of
RB02 were transformed with PROTet 6xHN (Clonetech, CA) plasmid with GFP
(VP01) to observe expression. The naïve cells with this construct are referred to
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as RB02G and the day 15 cells are reffered to as RB02-15G The following steps
were followed for the analysis.
Spectrophotmetric analysis
The cells were grown overnight and and diluted to 1:100 in fresh LB
medium. The cells were then transferred to a 96 well plate in triplicates and
grown at 37 °C in a spectrofluorometer for 18h. Through the period of 18h the
growth curve and the fluorescence of the cells were monitored.
Western blot
The cells were grown overnight and diluted in 1:100 to in fresh LB medium
and grown for 18 h. They were spun down and the lysates were analysed by
western blot.
The reagents used for western blot were
• Transfer buffer (25 mM Tris base, 192 mM glycine)
• Tris buffer saline with Tween-20 or TBS-T (20 mM Tris pH 7.5, 0.8% w/v
NaCl, 0.1% v/v Tween 20)
• Blocking buffer (TBS-T with 5% non fat dried milk)
• Primary antibody- anti GFP from goat aliquot stored in -20 °C, secondary
antibody anti goat antibody from donkey stored at 4 °C, Electro Chemi
Luminescence (ECL) Plus reagents stored at 4 °C (GE Healthcare, NJ)
The cells were subjected to Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis (SDS-PAGE) page at 250 V for 45m. PVDF transfer membranes
and Whatman absorbent papers was cut to appropriate dimensions. The PVDF
membrane was rinsed and soaked in 100% methanol, washed in DI water for 5m
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Figure 2.4. Plasmid map of PROTet 6x HNwith GFP.
This plasmid construct was transformed into both RB02 naive and RB02 day 15
cells in order to study the heterologous protein expression.
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and incubated in transfer buffer for 10m. The gel was incubated in transfer buffer
for 10m. The absorbent papers and the fiber pads were also soaked in transfer
buffer. The cassette was placed on a clean surface and the was arranged as in
Figure 2.5.
Figure 2.5. Assembly of the cassette for western blot.
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The cassette was placed in the buffer tank and filled with chilled transfer
buffer. This set-up was left over night at 4°C at 30 V with constant stirring. The
membrane was retrieved from the cassette and incubated in 15 ml blocking buffer
at room temperature with gentle shaking for 1h. The membrane was then rinsed
with 20 ml TBS-T. The membrane was incubated in 20 ml TBS-T for 5 minutes
with shaking. The buffer was discarded and the membran was washed with
TBS-T. 1:3000 dilution of anti GFP primary antibody was made in 30 ml of
TBS-T and added to the membrane. The membrane was incubated with the
antibody at room temperature for 1-2 h with gentle shaking. The membrane was
rinsed with 20 ml TBS-T. The membrane was incubated with TBS-T for 5
minutes with gentle shaking and washed thoroughly. The membrane was washed
3 times every 5m with a change in buffer after every wash. The secondary
antibody was diluted 1:5000 in 30 ml of TBS-T and incubated at room
temperature with gentle shaking for 1 hour. The membrane was washed with 20
ml TBS-T and then incubated with 30 ml TBS-T and washed after 5m. The
membraned was washed 3 times every 5m with a change in buffer after every
wash to get rid of the excess antibody. ECL plus reagents were equilibrated to
room temperature from 4°C. 4 ml of reagent A was mixed with 100 µl of reagent
B in a glass test tube wrapped in foil. The membrane was placed protein side up
on a SaranT M wrap and the mixed ECL reagent was added to it. This was
incubated at room temperature for 5m. After excess reagent was drained off a
small amount of water was added to the scanning bed and the blot was placed
protein side down for imaging.
Fluorescence Activated Cell Sorter (FACS)
The cells were grown overnight and diluted in 1:100 to in fresh LB medium
and grown for 18 hours. The cells were washed in 1x PBS with ampicillin. These
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cells were analysed on BD LSR II system (BD Biosciences) at an excitation
emmision of 490/525 nm.
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Chapter 3
Results and Discussion
3.1 Reproducing the GASP phenomenon
3.1.1 LacZ competition experiment
The LacZ competition experiment served as a preliminary test to reproduce
the GASP phenomenon. It was designed as a facile way to discriminate between
GASP and non-GASP phenotypes by competing them for the same pool of
resources. GASP and non-GASP phenotypes were discriminated on the basis of
their ability to metabolize X-gal.
The calibration assay for identifying the maximum activity of lac operon in
presence of X-gal showed that the cells did not show much difference between
30%, 40% and 50% Xgal. Figure 3.1 shows that the absorbance for the
dimerized indole ring peaked between 640 nm and 650 nm so for all further
experiments 645 nm was used as the wavelength and a concentration of 50%
X-gal was used. The cells started consuming X-gal after the 5th hour when they
were grown for 18h with 50% Xgal as shown in Figure 3.2.
Figure 3.3 shows the proportion of LacZ+ that could metabolize X-gal. The
curves represent a mixtureof LacZ + and LacZ - cells in varying proportions,
starting with 0% LacZ + to 100% LacZ + cells. It can be seen that with the
increase in proportion of LacZ + cells the curve has a higher peak. Figure 3.3
was used as a calibration curve for the competition assay.
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Figure 3.1. Colorimetric analysis of Xgal metabolism.
The LacZ+ cells were subjected to varying concentrations of Xgal. It can be
observed that there is little difference between curves representing 30%, 40% and
50% Xgal.
Figure 3.2. Calibration of Time.
Both LacZ+ and LacZ- cells were grown in 0% and 50% Xgal. The LacZ+ cells
in 50% Xgal show an increase in growth curve after the 5th hour.
Figure 3.4 shows results of competition assay between LacZ+ hour 20 and
LacZ- hour 2 and in 0% and 50% X-gal. It also shows the competition between
LacZ+ hour 2 and LacZ- hour 20 in 0% and 50% X-gal. When LacZ+20 and
LacZ-2 cells were competed against each other in 1:1 ratio it was observed that
LacZ+20 cells dominated. The calibration curves in Figure 3.3 was compared
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Figure 3.3. Proportion of LacZ cells in 50% X-gal.
The graph represents the curves of mixed cultures of LacZ + and LacZ - cells in
varying concentration. It can be seen that with the increasing concentration of
LacZ+ the graph shows a higher curve.
Figure 3.4. Competition assay results for lacZ cells.
The results showed that the older cells prevail over the younger cells. The graph
show the result for boxing match between LacZ+ hour 20 and LacZ- hour 2 in
0% and 50% X-gal for hour 10.
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Figure 3.5. Screening for GASP phenotype.
Image represents the colonies isolated from the assayed sample. The blue clonies
in image of the plate LacZ+20 vs. LacZ-2 at hour 10 dominate the plate. The
white colonies observed in image of the plate LacZ+2 vs. LacZ -20 at hour 10
indicate the domination of white colonies of the hour 20 LacZ- cells. Four
colonies were plated on each plate for ruling out experimental errors.
with Figure 3.4 and it was observed that the curve representing LacZ+20 and
LacZ-2 in 50% X-gal was in the same range as the 100% LacZ+ cells. This
showed that the LacZ+20 cells dominated the population.
Absorbance in Figure 3.4 was normalized and the growth trend was
subtracted from it so the exact ratio of cells that could metabolize X-gal could be
identified. From the graph it can be inferred that the older cells i.e GASP
phenotypes are able to metabolize X-gal faster.
The bar graph in Figure 3.5 shows that the aged cells dominated at all three
time points (hour 6, 8 and 10) in 50% X-gal which seems to indicates that the
GASP phenotypes that had emerged could metabolize X-gal faster and better
than its younger counterparts. The 0% X-gal samples were used as a control for
the competition assay. The control showed that in order to discriminate between
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the LacZ+20 and LacZ-2 cells X-gal was necessary. The presence of X-gal
introduced a media bias as only the LacZ+ cells could utilize it.
Single colonies that were isolated from these samples were plated on agar
plates with LB containing ampicillin and X-gal. The image of the plate shows
the older cells from hour 20 prevailing over the younger cells from hour 2. The
plate with LacZ+20 and LacZ-2 showed larger proportion of blue colonies
whereas the plate with LacZ+2 and LacZ-20 showed a larger proportion of white
colonies further confirming that the aged cells dominate.
Conclusions of the LacZ experiment
GASP phenomenon was successfully reproduced. The GASP phenotypes
tend dominate in as few as 20 hours. The absence of LacZ renders the LacZ- cells
unable to metabolize X-gal. This causes a media bias due to which aged LacZ-
cells could not be accurately identified. Colony counting does not provide
enough resolution to make conclusive inferences about the GASP phenotypes.
This preliminary experiment was improved upon by the Red-Green
competition experiment. This experiment used cells with fluorescent protein
markers, namely pmCherry and pVenus to distinguish between the GASP
phenotype and non-GASP phenotype. FACS was used to analyse the samples
which quantified the fluorescent cells accurately.
3.1.2 Quantification of competitive advantage of GASP
phenotype
The cells constructed in section 2.2.4 were used for competition assay and
the samples obtained from this experiment were analyzed using FACS which
gave an accurate count of fluorescent cells if each type in a given sample. The
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samples were simultaneously grown in LB and M9 media to ensure the
phenomenon observed was not caused by media dependency.
Figure 3.6. Competition assay results for DH5α cells with fluorescent proteins.
The day 15 PmCherry cells (solid red) out-competing the day 2 pVenus (solid
green) in LB and same results are observed in M9 minimal media.
Figure 3.6 shows the results obtained from FACS analysis. The results
showed that the aged cells out-competed the unaged cells.
Conclusions of the Red-Green fluorescence competition assay
The results from the Red-Green competition assay showed that the GASP
phenotype dominated over the non-GASP phenotype. The DH5α cells have recA
deletion. The recA gene is responsible for triggering the SOS response in a cell
which in turn triggers the activity of error prone nucleases thus enabling the cell
to benefit from possible error prone mutations (63). Since DH5α cells have recA
deletion this should not occur. rpoS was sequenced from all the cells used for
experiment- Day2, 12 and 15 of DH5α-mCherry and DH5α pVenus cells. This
sequence showed no relevant mutation. Even though there is no rpoS mutation
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GASP phenomenon is observed indicating that rpoS is not necessary for this
phenomenon to occur.
GASP phenomenon successfully reproduced
GASP is a reproducible phenomenon and it is observed that GASP phenotype
dominates over the non-GASP phenotype. This was confirmed by quantifying
the competitive advantage that these cells had via FACS. GASP phenotypes
could be exploited for synthetic biology as potential production platforms.
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3.2 Analysis of metabolic burden
Doubling time is one of the indicators of how much metabolic burden is
imposed on a cell. Higher metabolic burden increases the doubling time.
Metabolic burden of the cells with plasmid were compared with that of the cells
where the plasmids were integrated in the chromosome.
To quantify doubling time, growth curve data obtained was fit to the logistic
growth model. Statistical programming language R was used to run this model.
y =
(
Asymptote
1+ e
Xmid−input
scal
)
(3.1)
Where, Asymptote represents the maximum carrying capacity, Xmid represents
represents the time taken to get to half of the asymptotic value, Scal is inversely
proportional to the growth rate of the culture.
Figure 3.7. Doubling time calculated based on the Logistic growth model.
The graph shows doubling time for DH5α mCherry (mC), DH5α pVenus (pV),
K12mCherry (RB01) and K12pVenus (RB02). The plasmid based cells have a
slightly doubling time indicating higher metabolic burden.
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The values obtained from the model were used to plot Figure 3.7. Triplicate
samples were fit to the model to yield the value plotted on the bar graph. It can
be concluded from this experiment that cells with plasmids face higher metabolic
burden as compared to cells where the plasmid has been integrated in the
chromosome.
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3.3 Heterologous protein expression in GASP
phenotypes
This experiment was carried out to test the potential of GASP phenotypes as a
production platform for commercially relevant proteins. For testing this GFP was
used. There was approximately a two fold increase in the protein expression and
these results were observed across two different transformations. The cells were
tested in three ways - spectrophotometric analysis, western blotting, and FACS.
3.3.1 Spectrophotometric analysis
Growth curve of RB02 and RB02-15 were plotted along with normalized
fluorescence. Figure 3.8 indicates that RB02-15 cells have a slower growth rate
compared to RB02 cells. Figure 3.9 shows two fold increase in the expression of
GFP.
Figure 3.8. Growth curve of GASP phenotypes expressing GFP.
The growth curve graph represents growth rate for RB02-G (dot and dash) and
RB02-15 (solid line)
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Figure 3.9. Spectrophotometric Analysis heterologous protein expression.
The GFP expression graph represents R.F.U for RB02-G (dot and dash) and
RB02-15G(solid line)
3.3.2 Western blot
Lysates from aged and naïve cells were blotted onto a polyvinylidene fluoride
(PVDF) membrane and probed with anti-GFP antibodies. Band intensities were
quantified to measure the relative amount of protein in each cell. Figure 3.10
indicates normalized band intensities. The RB02-15G shows 2 fold increase in
the protein expression which is consistent with the spectrophotometric
observations.
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Figure 3.10. Quantitative western blot.
The inset image for quantitative western shows the band from the PVDF
membrane. The bar graph represents the intensities calculated from the
membrane.
3.3.3 FACS analysis
FACS was done on the RB02 and RB02-15 cells to analyze the fluorescence
per cell. The previous two methods quantified the total amount of protein which
could be an average of fluorescing and non-fluorescing cells in the sample.This
could be biased. FACS was used to rule out this ambiguity as it compared
fluorescence per cell of the two cultures. The cells were subjected to FACS after
18h of growth. 100,000 events were counted on the FACS and the fluorescent
events were counted and plotted. Figure 3.11 shows two fold increase in the
expression of the protein.
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Figure 3.11. FACS analysis.
The graphs shows result for FACS where RB02-15G shows increase in
expression.
Conclusion
The results observed for this experiment were really interesting, the aged
cells showed higher expression as compared to naïve cells. Approximately two
fold increase in expression of protein was observed in GASP phenotypes in
comparison to non-GASP phenotypes. The fluorescence per cells was observed
to increase as per the data from FACS and the growth rate. This increase in
expression indicates the fact that the GASP phenotypes could be exploited as a
chassis for production of proteins or other relevant compounds.
Table 3.1. Fold increase in expression
Method Approximate Fold Increase
Kinetic on TECAN 2.3
Quantitative western blot l.9
FACS 2.6
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3.4 Conclusions
GASP phenotypes were observed in both experiments indicating that GASP
phenomenon is reproducible through competitive assays. Competitive advantage
of GASP phenotypes over naïve cells was quantified and the proportion of GASP
cells were shown to increase with time indicating superior performance under
nutrient deprived conditions. The robustness displayed by the GASP phenotype
can most likely be attributed to the change in physiology of the cell. No
mutations were observed in rpoS indicating that rpoS does not play an exclusive
role in giving rise to GASP phenotypes. Cells with plasmids have a longer
doubling time showing that cells with plasmids face higher metabolic burden.
Furthermore, GASP phenotypes shows two fold increase in expression of
heterologous protein. They have a slower growth rate, yet produce higher
quantities of protein. Therefore, GASP phenotypes have a promising potential to
serve as robust chassis for implementing synthetic biology circuits.
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Chapter 4
Future Prospects
Since GASP phenotypes have shown to have a promising potential to serve as
a robust chassis for synthetic biology circuits, it is essential that the physiology
governing this phenomenon be examined in detail. The cause for increase in
protein expression as a result of change in physiology needs to be investigated.
The experiments in this project tested the expression of GFP, as a preliminary
case. As the GASP phenotypes have a slower growth rate and an increased
production of the protein it could significantly lower the production costs when
scaled up. The expression of other commercially relevant proteins need to be
tested in the GASP phenotypes to prove that these cells can indeed be used as a
chassis for production of proteins, possibly at a commercial level.
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